| 1 |
Mizgerd JP. Pathogenesis of severe pneumonia: advances and knowledge gaps[J]. Curr Opin Pulm Med, 2017, 23(3): 193-197.
|
| 2 |
Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis[J]. J Thromb Haemost, 2020, 18(7): 1738-1742.
|
| 3 |
Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure[J]. Thromb Haemost, 2020, 120(6): 998-1000.
|
| 4 |
Karasahin O, Tasar PT, Timur O, et al. The value of C-reactive protein in infection diagnosis and prognosis in elderly patients[J]. Aging Clin Exp Res, 2018, 30(6): 555-562.
|
| 5 |
Choi JJ, McCarthy MW. Novel applications for serum procalcitonin testing in clinical practice[J]. Expert Rev Mol Diagn, 2018, 18(1): 27-34.
|
| 6 |
李 萌，姚 莉，王 菁，等. NLR PLR在评估重症肺炎患者预后中的价值[J]. 安徽医学，2020, 41(4): 106-109.
|
| 7 |
Cai Z, He W, Zhuang FJ, et al. The role of high high-sensitivity C-reactive protein levels at admission on poor prognosis after acute ischemic stroke[J]. Int J Neurosci, 2019, 129(5): 423-429.
|
| 8 |
中国医师协会急诊医师分会. 中国急诊重症肺炎临床实践专家共识[J]. 中国急救医学，2016, 36(2): 97-107.
|
| 9 |
Gilani MT, Razavi M, Azad AM. A comparison of simplified acute physiology score Ⅱ，acute physiology and chronic health evaluation Ⅱ and acute physiology and chronic health evaluation Ⅲ scoring system in predicting mortality and length of stay at surgical intensive care unit[J]. Niger Med J, 2014, 55(2): 144-147.
|
| 10 |
Heppner HJ, Sehlhoff B, Niklaus D, et al. Pneumonia severity index (PSI), CURB-65, and mortality in hospitalized elderly patients with aspiration pneumonia[J]. Z Gerontol Geriatr, 2011, 44(4): 229-234.
|
| 11 |
Klopfenstein T, Zayet S, Lohse A, et al. Tocilizumab therapy reduced intensive care unit admissions and/or mortality in COVID-19 patients[J]. Med Mal Infect, 2020, 50(5): 397-400.
|
| 12 |
Chahin A, Opal SM. Severe pneumonia caused by legionella pneumophila：differential diagnosis and therapeutic considerations[J]. Infect Dis Clin North Am, 2017, 31(1): 111-121.
|
| 13 |
Spiezia L, Boscolo A, Poletto F, et al. COVID-19-related severe hypercoagulability in patients admitted to intensive care unit for acute respiratory failure[J]. Thromb Haemost, 2020, 120(6): 998-1000.
|
| 14 |
梁 欢，高 烨，苗常青，等. 中性粒细胞/淋巴细胞比值对重症肺炎患者28 d死亡风险的预测价值[J]. 中华危重病急救医学，2019, 31(7): 827-831.
|
| 15 |
Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis[J]. J Med Virol, 2020, 92(10): 1733-1734.
|
| 16 |
Zhou Y, Guo S, He Y, et al. COVID-19 is distinct from sars-cov-2-negative community-acquired pneumonia[J]. Front Cell Infect Microbiol, 2020, 10: 322.
|
| 17 |
Yang AP, Liu JP, Tao WQ, et al. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients[J]. Int Immunopharmacol, 2020, 84(12): 106-112.
|
| 18 |
Qu R, Ling Y, Zhang YH, et al. Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19[J]. J Med Virol, 2020, 92(9): 1533-1541.
|
| 19 |
Liu Y, Du X, Chen J, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19[J]. J Infect, 2020, 81(1): e6-e12.
|
| 20 |
Seyit M, Avci E, Nar R, et al. Neutrophil to lymphocyte ratio, lymphocyte to monocyte ratio and platelet to lymphocyte ratio to predict the severity of COVID-19[J]. Am J Emerg Med, 2021, 40(15): 110-114.
|
| 21 |
Ge YL, Liu CH, Xu J, et al. Serum high-sensitivity c reactive protein improves sensitivity of curb-65 in predicting icu admission and mortality in community-acquired pneumonia patients[J]. Clin Lab, 2018, 64(10): 1749-1754.
|
| 22 |
Nam KW, Kim TJ, Lee JS, et al. High neutrophil-to-lymphocyte ratio predicts stroke-associated pneumonia[J]. Stroke, 2018, 49(8): 1886-1892.
|
| 23 |
Lee JH, Song S, Yoon SY, et al. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio as diagnostic markers for pneumonia severity[J]. Br J Biomed Sci, 2016, 73(3): 140-142.
|
| 24 |
Wang C, Deng R, Gou L, et al. Preliminary study to identify severe from moderate cases of COVID-19 using combined hematology parameters[J]. Ann Transl Med, 2020, 8(9): 593.
|
| 25 |
姜迎厚，王 瑛，韩云宏，等. NLR评估老年重症肺炎严重程度及预后的价值[J]. 临床肺科杂志，2018, 23(12): 2170-2174.
|
| 26 |
Kartal O, Kartal AT. Value of neutrophil to lymphocyte and platelet to lymphocyte ratios in pneumonia[J]. Bratisl Lek Listy, 2017, 118(9): 513-516.
|
| 27 |
Neeser OL, Vukajlovic T, Felder L, et al. A high C-reactive protein/ procalcitonin ratio predicts Mycoplasma pneumoniae infection[J]. Clin Chem Lab Med, 2019, 57(10): 1638-1646.
|
| 28 |
Paul SP, De Aguiar A, Barnden J, et al. Outcomes of very high C-reactive protein levels in paediatric practice[J]. Br J Nurs, 2018, 27(1): 51.
|
| 29 |
Ali A, Abbasi AS, Amjad T, et al. Erythrocyte sedimentation rate and c-reactive protein as marker of acute versus chronic medical conditions[J]. J Ayub Med Coll Abbottabad, 2019, 31(1): 39-45.
|
| 30 |
周 燕. 重症肺部感染患者机械通气前后hs-CRP，PCT的变化情况及其与患者预后的关系分析[J]. 标记免疫分析与临床，2018, 25(2): 215-219+223.
|